Legacy Education Inc. Reports Strong Q2 FY 2025 Growth with 29% Revenue Increase and Record Enrollment
Legacy Education Inc. (NYSE: LGCY) reported strong financial results for Q2 FY2025. Revenue increased 29.2% to $13.6 million, with net income reaching $1.4 million and diluted EPS of $0.10. The company's student population grew 44.8% to 2,768, including students from the recently acquired Contra Costa Medical Career College.
For the six months ended December 31, 2024, revenue grew 32.1% to $27.6 million, with net income of $3.5 million and diluted EPS of $0.29. New student starts increased 16.2% during this period. The company's financial position shows $16.9 million in cash and cash equivalents, with total assets of $62.1 million.
The acquisition of Contra Costa Medical Career College, completed on December 18, contributed 389 students and is expected to show full financial impact in upcoming quarters. The company has surpassed 3,000 enrolled students as of January 31, 2025, marking a significant milestone in its growth strategy.
Legacy Education Inc. (NYSE: LGCY) ha riportato risultati finanziari solidi per il secondo trimestre dell'anno fiscale 2025. I ricavi sono aumentati del 29,2% raggiungendo 13,6 milioni di dollari, con un reddito netto di 1,4 milioni di dollari e un utile per azione diluito di 0,10 dollari. La popolazione studentesca dell'azienda è cresciuta del 44,8%, raggiungendo 2.768 studenti, inclusi quelli provenienti dal recentemente acquisito Contra Costa Medical Career College.
Per i sei mesi conclusi il 31 dicembre 2024, i ricavi sono cresciuti del 32,1% a 27,6 milioni di dollari, con un reddito netto di 3,5 milioni di dollari e un utile per azione diluito di 0,29 dollari. I nuovi iscritti sono aumentati del 16,2% durante questo periodo. La posizione finanziaria dell'azienda mostra 16,9 milioni di dollari in contante e equivalenti, con un totale di attivi di 62,1 milioni di dollari.
L'acquisizione del Contra Costa Medical Career College, completata il 18 dicembre, ha contribuito con 389 studenti e si prevede che mostri un impatto finanziario completo nei prossimi trimestri. L'azienda ha superato i 3.000 studenti iscritti al 31 gennaio 2025, segnando una pietra miliare significativa nella sua strategia di crescita.
Legacy Education Inc. (NYSE: LGCY) reportó resultados financieros sólidos para el segundo trimestre del año fiscal 2025. Los ingresos aumentaron un 29.2% a 13.6 millones de dólares, con una ganancia neta de 1.4 millones de dólares y un EPS diluido de 0.10 dólares. La población estudiantil de la empresa creció un 44.8% alcanzando los 2,768 estudiantes, incluidos los estudiantes de la recientemente adquirida Contra Costa Medical Career College.
Para los seis meses finalizados el 31 de diciembre de 2024, los ingresos crecieron un 32.1% a 27.6 millones de dólares, con una ganancia neta de 3.5 millones de dólares y un EPS diluido de 0.29 dólares. Los nuevos estudiantes iniciaron un 16.2% durante este período. La posición financiera de la empresa muestra 16.9 millones de dólares en efectivo y equivalentes, con activos totales de 62.1 millones de dólares.
La adquisición de Contra Costa Medical Career College, completada el 18 de diciembre, aportó 389 estudiantes y se espera que muestre un impacto financiero completo en los próximos trimestres. La empresa ha superado los 3,000 estudiantes matriculados al 31 de enero de 2025, marcando un hito significativo en su estrategia de crecimiento.
Legacy Education Inc. (NYSE: LGCY)는 2025 회계연도 2분기 강력한 재무 결과를 보고했습니다. 매출은 29.2% 증가하여 1,360만 달러에 달하며, 순이익은 140만 달러, 희석 주당순이익(EPS)은 0.10 달러에 이릅니다. 회사의 학생 수는 최근 인수한 Contra Costa Medical Career College의 학생들을 포함하여 44.8% 증가하여 2,768명에 달했습니다.
2024년 12월 31일로 종료된 6개월 동안 매출은 32.1% 증가하여 2,760만 달러에 도달했으며, 순이익은 350만 달러, 희석 EPS는 0.29 달러입니다. 이 기간 동안 신규 학생 수는 16.2% 증가했습니다. 회사의 재무 상태는 현금 및 현금성 자산이 1,690만 달러이며, 총 자산은 6,210만 달러입니다.
Contra Costa Medical Career College의 인수는 12월 18일에 완료되어 389명의 학생을 추가하였으며, 향후 분기에 완전한 재무적 영향을 미칠 것으로 예상됩니다. 회사는 2025년 1월 31일 기준으로 등록 학생 수가 3,000명을 초과하여 성장 전략에서 중요한 이정표를 세웠습니다.
Legacy Education Inc. (NYSE: LGCY) a annoncé de solides résultats financiers pour le deuxième trimestre de l'exercice 2025. Les revenus ont augmenté de 29,2 % pour atteindre 13,6 millions de dollars, avec un bénéfice net de 1,4 million de dollars et un BPA dilué de 0,10 dollar. La population étudiante de l'entreprise a augmenté de 44,8 % pour atteindre 2 768 étudiants, y compris ceux du récemment acquis Contra Costa Medical Career College.
Pour les six mois se terminant le 31 décembre 2024, les revenus ont augmenté de 32,1 % pour atteindre 27,6 millions de dollars, avec un bénéfice net de 3,5 millions de dollars et un BPA dilué de 0,29 dollar. Le nombre de nouveaux étudiants a augmenté de 16,2 % durant cette période. La situation financière de l'entreprise montre 16,9 millions de dollars en liquidités et équivalents, avec un total d'actifs de 62,1 millions de dollars.
L'acquisition de Contra Costa Medical Career College, finalisée le 18 décembre, a ajouté 389 étudiants et devrait montrer un impact financier complet dans les trimestres à venir. L'entreprise a dépassé les 3 000 étudiants inscrits au 31 janvier 2025, marquant une étape importante dans sa stratégie de croissance.
Legacy Education Inc. (NYSE: LGCY) hat starke finanzielle Ergebnisse für das zweite Quartal des Geschäftsjahres 2025 gemeldet. Der Umsatz stieg um 29,2% auf 13,6 Millionen US-Dollar, während der Nettogewinn 1,4 Millionen US-Dollar erreichte und der verwässerte Gewinn pro Aktie 0,10 US-Dollar betrug. Die Studentenzahl des Unternehmens wuchs um 44,8% auf 2.768, einschließlich der Studenten des kürzlich übernommenen Contra Costa Medical Career College.
Für die sechs Monate bis zum 31. Dezember 2024 wuchs der Umsatz um 32,1% auf 27,6 Millionen US-Dollar, mit einem Nettogewinn von 3,5 Millionen US-Dollar und einem verwässerten Gewinn pro Aktie von 0,29 US-Dollar. Die Zahl der neuen Studierenden stieg in diesem Zeitraum um 16,2%. Die finanzielle Lage des Unternehmens zeigt 16,9 Millionen US-Dollar in Bargeld und Zahlungsmitteläquivalenten, mit einer Gesamtbilanzsumme von 62,1 Millionen US-Dollar.
Die Übernahme des Contra Costa Medical Career College, die am 18. Dezember abgeschlossen wurde, brachte 389 Studenten hinzu und wird voraussichtlich in den kommenden Quartalen volle finanzielle Auswirkungen zeigen. Das Unternehmen hat am 31. Januar 2025 mehr als 3.000 eingeschriebene Studenten überschritten, was einen bedeutenden Meilenstein in seiner Wachstumsstrategie darstellt.
- Revenue growth of 29.2% YoY to $13.6M in Q2 FY2025
- 44.8% increase in student population to 2,768
- Net income of $1.4M with positive EPS of $0.10
- Strong cash position of $16.9M
- Strategic acquisition of Contra Costa Medical Career College adding 389 students
- Surpassed 3,000 enrolled students milestone
- Educational services expenses increased 35.3% YoY
- General and administrative expenses rose 32.5% YoY
- Bad debt expense increased (amount not specified)
Insights
Legacy Education's Q2 FY2025 results reveal a compelling growth story with several key strengths and some areas warranting attention. The
The company's operational metrics show strong fundamentals. The student population increase of
However, investors should note the cost structure dynamics. Educational services expenses grew
The balance sheet remains solid with
Looking ahead, the surpassing of 3,000 enrolled students in January 2025 indicates continued momentum. The focus on healthcare education through the Contra Costa acquisition appears well-timed given persistent healthcare workforce shortages. The company's ability to maintain enrollment growth while managing integration costs and regulatory compliance will be important for sustaining this positive trajectory.
Legacy Education Inc. will host a conference call to discuss its first quarter financial results on Thursday, February 13, 2025 at 4:30 p.m. Eastern time.
To access the live webcast of the conference call, please go to the investor relations section of the Legacy Education website at www.legacyed.com. Participants may also register via teleconference at Q2 FY 2025 Legacy Education Inc. Earnings Conference Call. Once registration is completed, participants will be provided with a dial-in number containing a personalized PIN to access the call. Participants are requested to register at a minimum 15 minutes before the start of the call. An archived version of the webcast will be accessible for 90 days at www.legacyed.com. Toll-free dial-in number is 877-407-9785 and international dial-in number is +1-201-689-8843.
Second Quarter 2025 Financial Highlights
- Revenue grew
29.2% to$13.6 million - New student starts increased
3.0% - EBITDA of
$1.8 million $1.9 million - Net income of
$1.4 million - Diluted earnings per share of
$0.10 - Student population of 2,768 (including Contra Costa Medical Career College), a
44.8% increase from the second fiscal quarter of 2024
Six months ended December 31, 2024 Financial Highlights
- Revenue grew
32.1% to$27.6 million - New student starts increased
16.2% - EBITDA of
$4.5 million $4.7 million - Net income of
$3.5 million - Diluted earnings per share of
$0.29
"While the second fiscal quarter reflected the seasonal trends we anticipated, we are energized by the strategic investments we've made in our team, facilities and programs. Additionally, our recent acquisition of
QUARTER END FINANCIAL RESULTS
Quarter ended December 31, 2024 compared to December 31 , 2023
- Revenue was approximately
$13.6 million $10.5 million $3.1 million 29.2% . The increase is primarily due to a44.8% increase in ending enrollment from 1,912 to 2,768 supported by a3.0% increase in starts from 337 to 347 in the quarter compared to prior year as well as the acquisition of CCMCC adding 389 students. - Educational services expense was approximately
$7.5 million $5.5 million $1.9 million 35.3% . The increase was primarily attributable to the increased instructional and staffing required to support the increase in enrollments as well as increased rent and externship fees and public company costs and our investments in our RN program. - General and administrative expense was approximately
$4.3 million $3.2 million $1.1 million 32.5% . The increase was primarily attributable to an increase in marketing expense, professional fees, bad debt expense and public company costs. Of the total general and administrative expense,$1.2 million $1.0 million
YEAR TO DATE FINANCIAL RESULTS
Six Months December 31, 2024 compared to December 31 , 2023
- Revenue was approximately
$27.6 million $20.9 million $6.7 million 32.1% . The increase is primarily due to a44.8% increase in ending enrollment from 1,912 to 2,768 supported by a16.2% increase in starts from 964 to 1,120 in the quarter compared to prior year as well as the acquisition of CCMCC adding 389 students. - Educational services expense was approximately
$14.7 million $11.3 million $3.5 million 30.4% . The increase was primarily attributable to the increased instructional and staffing required to support the increase in enrollments as well as increased rent and externship fees and public company costs and our investments in our RN program. - General and administrative expense was approximately
$8.3 million $6.4 million $1.9 million 29.2% . The increase was primarily attributable to an increase in marketing expense, professional fees, bad debt expense and public company costs. Of the total general and administrative expense,$2.3 million $2.1 million
Three Months Ended | Six Months Ended | ||||
December 31 | December 31 | ||||
2024 | 2023 | 2024 | 2023 | ||
REVENUE | |||||
Tuition and related income, net | $ 13,635,134 | $ 10,551,297 | $ 27,640,225 | $ 20,918,231 | |
OPERATING EXPENSES | |||||
Educational services | 7,479,226 | 5,526,347 | 14,683,800 | 11,258,473 | |
General and administrative | 4,349,129 | 3,281,201 | 8,315,176 | 6,435,606 | |
General and administrative - related party | 43,147 | 42,000 | 124,200 | 84,000 | |
Depreciation and amortization | 105,839 | 63,303 | 186,980 | 121,162 | |
Total costs and expenses | 11,977,341 | 8,912,851 | 23,310,156 | 17,899,241 | |
OPERATING INCOME | 1,657,793 | 1,638,446 | 4,330,069 | 3,018,990 | |
Interest expense | (28,318) | (35,269) | (57,668) | (63,535) | |
Interest income | 295,522 | 178,575 | 556,418 | 321,709 | |
Total other income | 267,204 | 143,306 | 498,750 | 258,174 | |
INCOME BEFORE INCOME TAXES | 1,924,997 | 1,781,752 | 4,828,819 | 3,277,164 | |
Income tax expense | (525,951) | (491,791) | (1,339,020) | (917,607) | |
Net income (loss) | $ 1,399,046 | $ 1,289,961 | $ 3,489,799 | $ 2,359,557 | |
Net income per share | |||||
Basic net income per share | $ 0.11 | $ 0.14 | $ 0.32 | $ 0.25 | |
Diluted net income per share | $ 0.10 | $ 0.13 | $ 0.29 | $ 0.24 | |
Basic weighted average shares outstanding | 12,254,453 | 9,291,149 | 10,787,640 | 9,291,149 | |
Diluted weighted average shares outstanding | 13,417,823 | 9,691,149 | 11,951,010 | 9,691,149 | |
Selected Consolidated Balance Sheet Data: | December 31, 2024 | ||||
(unaudited) | |||||
Cash and cash equivalents | $ 16,869,726 | ||||
Current assets | 31,860,458 | ||||
Working capital | 18,926,980 | ||||
Total assets | 62,069,876 | ||||
Current liabilities | 12,933,478 | ||||
Total stockholders' equity | 36,414,430 | ||||
Important Information Regarding Non-GAAP Financial Information
To supplement Legacy Education's consolidated financial statements presented in accordance with GAAP, Legacy Education furnishes certain adjusted non-GAAP supplemental information to our financial results regarding EBITDA and adjusted EBITDA. This reconciliation adjust the related GAAP financial measures to exclude operating income to adjust the impact of non cash compenation in the periods presented. We use such adjusted non-GAAP financial measures to evaluate our period-over-period operating performance because our management team believes that by excluding the effects of such adjusted GAAP-related items that, in their opinion, do not reflect the ordinary earnings of our operations, it enhances investors' overall understanding of our current financial performance and our prospects for the future by (i) providing a more comparable measure of our continuing business, as well as greater understanding of the results from the primary operations of our business, (ii) affording a view of our operating results that may be more easily compared to our peer companies, and (iii) enabling investors to consider our operating results on both a GAAP and adjusted non-GAAP basis (including following the integration period of our prior and proposed acquisitions). However, this adjusted non-GAAP information is not in accordance with, or an alternative to, generally accepted accounting principles in the United States ("GAAP") and should be considered in conjunction with our GAAP results as the items excluded from the adjusted non-GAAP information may have a material impact on Legacy's financial results. A reconciliation of adjusted non-GAAP adjustments to Legacy's GAAP financial results is included in the tables at the end of this press release.
In the noted fiscal periods, we adjusted net income for the items identified from our GAAP financial results to arrive at our adjusted non-GAAP financial measures:
Stock-based compensation - We exclude stock-based compensation to be consistent with the way management and, in our view, the overall financial community, evaluates our performance and the methods used by analysts to calculate consensus estimates. The expense related to stock-based awards is generally not controllable in the short-term and can vary significantly based on the timing, size and nature of awards granted. As such, we do not include these charges in operating plans.
RECONCILIATION OF NET INCOME, EBITDA, AND ADJUSTED EBITDA
Three Months Ended | Six Months Ended | ||||
December 31 | December 31 | ||||
2024 | 2023 | 2024 | 2023 | ||
Net income | $ 1,399,046 | $ 1,289,961 | $ 3,489,799 | $ 2,359,557 | |
Interest expense (income), net | (267,204) | (143,306) | (498,750) | (258,174) | |
Provision for income taxes | 525,951 | 491,791 | 1,339,020 | 917,607 | |
Depreciation and amortization | 105,839 | 63,303 | 186,980 | 121,162 | |
EBITDA | 1,763,632 | 1,701,749 | 4,517,049 | 3,140,152 | |
Non cash compensation | 109,157 | 0 | 176,188 | 0 | |
Adjusted EBITDA | $ 1,872,789 | $ 1,701,749 | $ 4,693,237 | $ 3,140,152 | |
ABOUT LEGACY EDUCATION
Legacy Education (NYSE: LGCY) is an award-winning, nationally accredited, for-profit post-secondary education company founded in 2009. Legacy Education provides career-focused education primarily in the healthcare field, with certificates and degrees for nursing, medical technicians, dental assisting, business administrative, and several others. The company offers a wide range of educational programs and services to help students achieve their professional goals. Legacy Education's focus is on providing high-quality education that is accessible and affordable. Legacy Education is committed to growing it's education footprint via organic enrollment growth, addition of new programs and accretive acquisitions. For more information, please visit www.legacyed.com or on LinkedIn @legacy-education-inc.
FORWARD-LOOKING STATEMENTS
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates, expected use of proceeds, the Company's operations and business strategy and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including, without limitation, market conditions and the factors described in the section entitled "Risk Factors" in Legacy's most recent Annual Report on Form 10-K and Legacy's other filings made with the
Contact Legacy Education Inc.
Investor Relations
ir@legacyed.com
Amato and Partners, LLC
Investors Relations Counsel
admin@amatoandpartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/legacy-education-inc-reports-strong-q2-fy-2025-growth-with-29-revenue-increase-and-record-enrollment-302376097.html
SOURCE Legacy Education Inc.
FAQ
What was Legacy Education's (LGCY) revenue growth in Q2 FY2025?
How many students did LGCY have after acquiring Contra Costa Medical Career College?
What was Legacy Education's (LGCY) net income for Q2 FY2025?
How much cash does Legacy Education (LGCY) have as of December 31, 2024?
When did LGCY acquire Contra Costa Medical Career College?
